Showing results (271-280 of 531) with videos related to
Sort By:
Pageof 54
Bulletin of Mathematical Biology|January 1, 1990
Experimental determination and mathematical model of the transient incorporation of cholesterol in the arterial wallS J Neumann, S A Berceli, E M Sevick, et al.American Journal of Cardiovascular Disease|March 8, 2013
Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromesDharam J Kumbhani, Brian J Wells, A Michael Lincoff, et al.JACC. Cardiovascular Interventions|May 26, 2009
Impact of drug-eluting versus bare-metal stents on mortality in patients with anemiaMehdi H Shishehbor, Steven J Filby, Adnan K Chhatriwalla, et al.American Heart Journal|June 30, 2000
Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockadeD J Kereiakes, S D Berkowitz, A M Lincoff, et al.European Journal of Neurology|April 16, 2013
Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritisA Kardys, B Weinstock-Guttman, M Dillon, et al.Journal of the American Heart Association|March 23, 2019
Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-AnalysisSafi U Khan, Hammad Rahman, Victor Okunrintemi, et al.Chest|July 24, 2008
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Robert A Harrington, Richard C Becker, Christopher P Cannon, et al.The American Journal of Cardiology|July 13, 2004
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortalityVivek Rajagopal, Hitinder S Gurm, Deepak L Bhatt, et al.Journal of the American College of Cardiology|November 3, 2004
Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trialDavid J Cohen, A Michael Lincoff, Tara A Lavelle, et al.Archives of Internal Medicine|October 24, 2007
Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO VHarmony R Reynolds, Michael E Farkouh, A Michael Lincoff, et al.Pageof 54